Inhaled glucocorticoids in chronic obstructive pulmonary disease

New England Journal of Medicine

Volumn 343, Issue 26 I, 2000, Pages 1960-1961

  Mapp, C E ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; FLUTICASONE; GLUCOCORTICOID; METHACHOLINE; TRIAMCINOLONE;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DISEASE SEVERITY; EDITORIAL; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MEDICAL SOCIETY; OSTEOPOROSIS; PRIORITY JOURNAL; SMOKING CESSATION; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; BRONCHIAL HYPERREACTIVITY; DISEASE PROGRESSION; FORCED EXPIRATORY VOLUME; GLUCOCORTICOIDS; HUMANS; LUNG DISEASES, OBSTRUCTIVE; TRIAMCINOLONE;

EID: 0034727837     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200012283432609     Document Type: Editorial

References (10)

1. 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma
2. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease
3. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking
4. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: A randomised controlled trial
5. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: The ISOLDE trial
6. 1: The Lung Health Study
7. COPD: Present and future concepts: Economic perspectives
8. Histamine airway hyper-responsiveness and mortality from chronic obstructive pulmonary disease: A cohort study
9. Low-dose inhaled corticosteroids and the prevention of death from asthma